|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
(none)
|
|
INDICATIONS:
|
|
Anemia, iron- deficiency |
|
Deficiency, iron |
| |
|
|
SIDE EFFECTS:
|
|
abdominal pain |
|
acute generalized exanthematous pustulosis (AGEP) |
|
anorexia |
|
constipation |
|
diarrhea |
|
dyspepsia |
|
dysphagia |
|
esophageal stricture |
|
esophageal ulceration |
|
esophagitis |
|
hemosiderosis |
|
nausea/vomiting |
|
odynophagia |
|
oral ulceration |
|
stool discoloration |
|
tooth discoloration |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
accidental exposure |
|
anemia |
|
breast-feeding |
|
children |
|
colitis |
|
dysphagia |
|
GI disease |
|
GI obstruction |
|
hemolytic anemia |
|
hepatic disease |
|
ileus |
|
infants |
|
inflammatory bowel disease |
|
neonates |
|
peptic ulcer disease |
|
porphyria |
|
pregnancy |
|
|
ADULT DOSE:
|
|
Deficiency (prophylaxis)-
Oral, amount based on normal daily recommended intakes of elemental iron:
Persons U.S. Canada
(mg) (mg)
Adolescent and adult males 10 8-10
Adolescent and adult females 10-15 8-13
Pregnant females 30 17-22
Breast-feeding females 15 8-13
Deficiency (treatment)-
Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Deficiency (prophylaxis)-
Oral, amount based on normal daily recommended intakes of elemental iron:
Persons U.S. Canada
(mg) (mg)
Infants and children 6-10 0.3-6
Birth to 3 years of age
4 to 6 years of age 10 8
7 to 10 years of age 10 8-10
Deficiency (treatment)-
Treatment dose is individualized by prescriber based on severity of deficiency. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|